VYNE Therapeutics (VYNE) Finished Goods (2021)
VYNE Therapeutics (VYNE) posted Finished Goods of $4.0 million for Q4 2021.
VYNE Therapeutics (VYNE) Finished Goods (2021) Analysis & Trends
VYNE Therapeutics' Finished Goods history runs 1 years deep, the most recent figure standing at $4.0 million for Q4 2021.
- Quarterly Finished Goods changed N/A year-over-year to $4.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $4.0 million (changed N/A YoY) and the FY2021 annual result came in at $4.0 million, changed N/A from the prior year.
- Finished Goods was $4.0 million for Q4 2021 at VYNE Therapeutics.
- Across five years, Finished Goods topped out at $4.0 million in Q4 2021 and bottomed at $4.0 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 4.00 Mn |